Style | Citing Format |
---|---|
MLA | Toupchian O, et al.. "Dha-Enriched Fish Oil Upregulates Cyclin-Dependent Kinase Inhibitor 2A (P16 Ink ) Expression and Downregulates Telomerase Activity Without Modulating Effects of Pparγ Pro12ala Polymorphism in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial." Clinical Nutrition, vol. 37, no. 1, 2018, pp. 91-98. |
APA | Toupchian O, Sotoudeh G, Mansoori A, Abdollahi S, Ali Keshavarz S, Djalali M, Nasliesfahani E, Alvandi E, Chahardoli R, Koohdani F (2018). Dha-Enriched Fish Oil Upregulates Cyclin-Dependent Kinase Inhibitor 2A (P16 Ink ) Expression and Downregulates Telomerase Activity Without Modulating Effects of Pparγ Pro12ala Polymorphism in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Clinical Nutrition, 37(1), 91-98. |
Chicago | Toupchian O, Sotoudeh G, Mansoori A, Abdollahi S, Ali Keshavarz S, Djalali M, Nasliesfahani E, Alvandi E, Chahardoli R, Koohdani F. "Dha-Enriched Fish Oil Upregulates Cyclin-Dependent Kinase Inhibitor 2A (P16 Ink ) Expression and Downregulates Telomerase Activity Without Modulating Effects of Pparγ Pro12ala Polymorphism in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial." Clinical Nutrition 37, no. 1 (2018): 91-98. |
Harvard | Toupchian O et al. (2018) 'Dha-Enriched Fish Oil Upregulates Cyclin-Dependent Kinase Inhibitor 2A (P16 Ink ) Expression and Downregulates Telomerase Activity Without Modulating Effects of Pparγ Pro12ala Polymorphism in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial', Clinical Nutrition, 37(1), pp. 91-98. |
Vancouver | Toupchian O, Sotoudeh G, Mansoori A, Abdollahi S, Ali Keshavarz S, Djalali M, et al.. Dha-Enriched Fish Oil Upregulates Cyclin-Dependent Kinase Inhibitor 2A (P16 Ink ) Expression and Downregulates Telomerase Activity Without Modulating Effects of Pparγ Pro12ala Polymorphism in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Clinical Nutrition. 2018;37(1):91-98. |
BibTex | @article{ author = {Toupchian O and Sotoudeh G and Mansoori A and Abdollahi S and Ali Keshavarz S and Djalali M and Nasliesfahani E and Alvandi E and Chahardoli R and Koohdani F}, title = {Dha-Enriched Fish Oil Upregulates Cyclin-Dependent Kinase Inhibitor 2A (P16 Ink ) Expression and Downregulates Telomerase Activity Without Modulating Effects of Pparγ Pro12ala Polymorphism in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial}, journal = {Clinical Nutrition}, volume = {37}, number = {1}, pages = {91-98}, year = {2018} } |
RIS | TY - JOUR AU - Toupchian O AU - Sotoudeh G AU - Mansoori A AU - Abdollahi S AU - Ali Keshavarz S AU - Djalali M AU - Nasliesfahani E AU - Alvandi E AU - Chahardoli R AU - Koohdani F TI - Dha-Enriched Fish Oil Upregulates Cyclin-Dependent Kinase Inhibitor 2A (P16 Ink ) Expression and Downregulates Telomerase Activity Without Modulating Effects of Pparγ Pro12ala Polymorphism in Type 2 Diabetic Patients: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial JO - Clinical Nutrition VL - 37 IS - 1 SP - 91 EP - 98 PY - 2018 ER - |